Riskpilot← Back to searchSign inGet full accessNeuromathic AB
ABActiveOrg 5590958988Karl X Gustavs Gata 61 BResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20170 employees
Revenue 2025
SEK 0
EBITDA margin
—
-37% vs 2024
Equity ratio
54.7%
Financial strength
Net profit 2025
SEK 39K
+381% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -20K | -37% |
| Net profit | SEK 39K | +381% |
| Total assets | SEK 671K | +3% |
| Equity | SEK 367K | +12% |
| Employees | 0 | — |
Legal name
Neuromathic AB
Org number
5590958988
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
3 januari 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva mjukvaru- utveckling och hårdvaruutveckling, äga och förvalta fastigheter, samt idka därmed förenlig verksanhet.
Address
Karl X Gustavs Gata 61 B
Email
rikard@neuromathic.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −16 | −15 | −16 | −14 | −20 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −16 | −15 | −16 | −14 | −20 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | −16 | −15 | 14 | −14 | 44 |
| Tax | −0 | — | — | — | −5 |
| Net profit | −16 | −15 | 14 | −14 | 39 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 660 | 644 | 664 | 650 | 671 |
| Equity | 343 | 328 | 342 | 328 | 367 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 216 | 215 | 251 | 251 | 296 |
| Total debt | 216 | 215 | 251 | 251 | 296 |
EBITDA margin
-1952200.0%
This company
15.8%
Market median
-12355796% vs market
20212025
Equity ratio
54.7%
This company
38.2%
Market median
+43% vs market
20212025
Return on equity
10.6%
This company
18.4%
Market median
+42% vs market
20212025
Net profit margin
3885400.0%
This company
8.1%
Market median
+47967801% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.83×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RJ Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
PO | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Chairman | 2025 | |
| Former (1) | ||
| Chairman | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Neuromathic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rikard Josef Berthilsson | Chief Executive Officer | 0 companies |
| Paul Olof Jakob Ekman | Audit | 0 companies |
| Stefan Johan Spiridon Vlachos | Chairman | 0 companies |
| Jessica Blenda Virginia Wastring | Deputy Board Member | 0 companies |
| Karl Erik Åström | Chairman | 0 companies |